1,7-phenanthroline has been researched along with Neurodegenerative Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boldron, C; Deraeve, C; Gornitzka, H; Meunier, B; Pitié, M; Van der Auwera, I; Van Leuven, F; Wera, S | 1 |
1 other study(ies) available for 1,7-phenanthroline and Neurodegenerative Diseases
| Article | Year |
|---|---|
Preparation of cyclo-phen-type ligands: chelators of metal ions as potential therapeutic agents in the treatment of neurodegenerative diseases.
Topics: Alzheimer Disease; Animals; Chelating Agents; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Ions; Ligands; Macrocyclic Compounds; Metals; Mice; Mice, Transgenic; Molecular Structure; Neurodegenerative Diseases; Phenanthrolines; Plaque, Amyloid | 2005 |